Inovio Pharmaceuticals Inc (NASDAQ:INO)

4.64
Delayed Data
As of 4:00pm ET
 +0.01 / +0.22%
Today’s Change
3.76
Today|||52-Week Range
9.86
+12.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues10.4M20.4M2.6M8.8M
 
 
 
 
 
Depreciation And Amortization928.6K902.6K1.2M474.4K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses31.4M29.1M30.7M32.2M
 
 
 
 
 
Research And Development24.5M23.9M25.5M24.6M
 
 
 
 
 
Total Operating Expenses32.3M30.0M31.8M32.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.9M-9.6M-29.2M-23.9M
 
 
 
 
 
Extraordinary Credit116.5K0.00423.3K579.5K
 
 
 
 
Extraordinary Charge0.00-312.5K--0.00
 
 
Other Expenses-1.3M469.1K-5.4M1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.1M-9.5M-34.1M-21.5M
 
 
 
 
 
Net Income-23.1M-9.5M-34.1M-21.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS74.2M75.4M87.0M90.4M
 
 
 
 
 
Shares To Calculate EPS Diluted74.3M75.4M87.1M92.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.13-$0.39-$0.24
 
 
 
 
 
EPS Diluted-$0.31-$0.13-$0.39-$0.24